Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
viscum engleri/vähk
Link salvestatakse lõikelauale
13 tulemused
Trial of Mistletoe Extract in Patients With Advanced Solid Tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This study is a Phase I study that consists of two phases: a dose escalation phase and an expansion phase. The dose escalation phase will be used to evaluate the safety and toxicity of Helixor® M (mistletoe extract). An accelerated titration design (ATD) will be utilized to determine the MTD. The
Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Extracts from European mistletoe (Viscum album L.) have been used as complementary cancer therapy since the 1920s. To date over 160 clinical studies on mistletoe in cancer therapy have been conducted with varying quality; the therapy is still controversial.
Best evidence is found for increase of
Therapeutic Instillation of Mistletoe
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This is a randomized, open-label, active-controlled, prospective, multinational Phase III confirmative study with 2 treatment groups and an adaptive design (Bauer and Köhne, 1994). The study is designed to compare the efficacy of treatment with abnobaVISCUM® 900 with Mitomycin C (MMC). Patients with
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
see summary
Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
see summary
Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The study design is to include 90 subjects. All subjects are treated with the common chemotherapy treatment. 50 percent will be treated with Iscador as combination with their common chemotherapy regimen. Common chemotherapy regimen used for NSCLC: Carboplatin and Gemcitabine. All study participants
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The study consists of three parts. Part 1 is a prospective non-randomized feasibility study in patients with breast cancer after primary surgery during chemotherapy or endocrine therapy comparing blood count, lymphocytes, quality of life and local and general side effects between the groups Part 2
Iscar for Supplemental Care in Stage IV Lung Cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
See Brief Summary
Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVES:
- Determine whether supplemental treatment with mistletoe increases immune function (as determined by total lymphocyte count, eosinophil count, and lymphocyte subset analysis) in patients with stage IIIB or IV non-small cell lung cancer receiving palliative chemotherapy.
- Determine the
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVES:
- Determine the maximum tolerated dose of gemcitabine and mistletoe in patients with advanced solid tumors.
- Determine the toxic effects of this regimen in these patients.
- Determine the pharmacokinetic effects of gemcitabine with and without mistletoe in these patients.
- Determine
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVES:
- Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy.
- Determine the optimal biologically active dose of mistletoe lectin based on analysis of specific
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVES:
- Determine the maximum tolerated dose and dose-limiting toxicity of mistletoe lectin (recombinant viscumin) in patients with advanced solid tumors who have failed standard therapy.
- Determine the pharmacokinetics of this regimen in these patients.
- Determine whether induction of
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
